|
|
||||||||
Divisions of 1Pulmonary and Critical Care Medicine and 2Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; 3Department of Specialty Care Services, University of Texas, Tyler, Texas; and 4Sunol Molecular, Miramar, Florida
Submitted 7 April 2005 ; accepted in final form 4 August 2005
Tissue factor expression in sepsis activates coagulation in the lung, which potentiates inflammation and leads to fibrin deposition. We hypothesized that blockade of factor X binding to the tissue factor-factor VIIa complex would prevent sepsis-induced damage to the lungs and other organs. Acute lung injury was produced in 15 adult baboons primed with killed Escherichia coli [1 x 109 colony-forming units (CFU)/kg], and then 12 h later, they were given 1 x 1010 CFU/kg live E. coli by infusion. Two hours after live E. coli, animals received antibiotics with or without monoclonal antibody to tissue factor intravenously to block tissue factor-factor X binding. The animals were monitored physiologically for 34 h before being killed and their tissue harvested. The antibody treatment attenuated abnormalities in gas exchange and lung compliance, preserved renal function, and prevented tissue neutrophil influx and bowel edema relative to antibiotics alone (all P < 0.05). It also attenuated fibrinogen depletion (P < 0.01) and decreased proinflammatory cytokines, e.g., IL-6 and -8 (P < 0.01), in systemic and alveolar compartments. Similar protective effects of the antibody on IL-6 and -8 expression and permeability were found in lipopolysaccharide-stimulated endothelial cells. Blockade of factor X binding to the tissue factor-factor VIIa complex attenuates lung and organ injuries in established E. coli sepsis by attenuating the neutrophilic response and inflammatory pathways.
thromboplastin; adult respiratory distress syndrome; multiple organ failure; septicemia; Papio
This article has been cited by other articles:
![]() |
J. A. Bastarache, L. Wang, Z. Wang, K. H. Albertine, M. A. Matthay, and L. B. Ware Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L874 - L881. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Bastarache, L. Wang, T. Geiser, Z. Wang, K. H Albertine, M. A Matthay, and L. B Ware The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor Thorax, July 1, 2007; 62(7): 608 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahamed, F. Niessen, T. Kurokawa, Y. K. Lee, G. Bhattacharjee, J. H. Morrissey, and W. Ruf Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia Blood, June 15, 2007; 109(12): 5251 - 5259. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Ware, E. Camerer, K. Welty-Wolf, M. J. Schultz, and M. A. Matthay Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L307 - L311. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |